Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN
10109-cover-brainscan.jpg

March 13, 2023 Cover

Volume 101, Issue 9

Unlike bulky biologics, small molecules can make Alzheimer’s treatments cheap, convenient to administer, and widely accessible, experts say

Cover image:Alzheimer's disease affects millions of people around the globe every year. Small-molecule drug candidates could provide practical and affordable treatments.

Credit: Luisa Jung

Full Article

Why lecanemab’s success spells the revival of small-molecule Alzheimer’s treatments

Unlike bulky biologics, small molecules can make Alzheimer’s treatments cheap, convenient to administer, and widely accessible, experts say

  • Measuring the protein-metabolite interactome

    Researchers have already uncovered many previously unknown PMIs with mass spec technique

  • BlackInChem cofounder Samantha T. Mensah dies at 28

    The UCLA chemistry graduate student advanced representation of Black researchers in the chemical sciences

  • ACS honors its 2023 Outreach Volunteers of the Year

    Evonne Baldauff of the Pittsburgh Section is named the global winner

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT